Ampio Pharmaceuticals Announces Registered Direct Common Stock Offering of Approximately $9.4... ( GREENWOOD VILLAGE Colo. Dec. 21 2011 ...)

Navigation Links

Biology News Medicine News Biology Products Medicine Products Biology Definition Medicine Definition Biology Technology Medicine Technology Biology Dictionary Medicine Dictionary

HOME >> MEDICINE >> TECHNOLOGY

Ampio Pharmaceuticals Announces Registered Direct Common Stock Offering of Approximately $9.436 Million

Date:12/21/2011

GREENWOOD VILLAGE, Colo., Dec. 21, 2011 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (Nasdaq: AMPE)("Ampio" or the "Company"), a company that discovers and develops new uses for previously approved drugs and new molecular entities ("NMEs"), announced today that it has entered into definitive agreements with accredited investors to sell an aggregate approximately 2,220,255 of shares of its common stock, par value $0.0001 per share (the "Shares"), at a price per share of $4.25 in a registered direct offering for gross proceeds of approximately $9.436 million, before deducting placement agents' fees and estimated offering expenses.

The Shares are being offered directly by Ampio pursuant to an effective shelf registration statement previously filed with, and declared effective by the Securities and Exchange Commission on October 28, 2011. The Company anticipates that the net proceeds from the offering will be used for general corporate purposes and working capital. The closing of this offering is expected to occur on or about December 27, 2011, subject to the satisfaction of customary closing conditions.

Fordham Financial Management, Inc. and Summer Street Research Partners served as co- lead placement agents and Emerging Growth Equities, Ltd. served as the co-placement agent for the offering. When available, copies of the preliminary prospectus supplement, the prospectus supplement and the accompanying base prospectus relating to the offering may be obtained from the Securities and Exchange Commission website at http://www.sec.gov or Fordham Financial Management, Inc., 14 Wall Street, New York, New York 10005.

This press release does not and shall not constitute an offer to sell or the solicitation of an offer to buy any of the securities, nor shall there be any sale of the securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration of qualifica
'/>"/>

SOURCE Ampio Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3
Related medicine technology :

1. Ampio Responds to Recent Publications by Anonymous Short Sellers
2. Champions Oncology Reports Fiscal 2012 Second Quarter Financial Results
3. FDA Advisory Panel Recommends Against Approval of Champion® Heart Failure Management System for Patients With Heart Failure
4. Ampio Pharmaceuticals Awarded European Patent that Strengthens Intellectual Property Protection for its key drug Ampion™
5. Ampio Pharmaceuticals Announces Agreement to Acquire Key Drug Delivery Technology
6. Ampio Pharmaceuticals Expands Patent Portfolio of Drugs for Treating Inflammatory Diseases
7. Ampio Pharmaceuticals Announces Positive Results on Ampion™ Trial for Relief of Nasal Inflammation
8. Champions Oncology, Inc. Appoints Executive Vice President and Chief Financial Officer to Management Team and Corporate Office Relocation
9. Ampio Pharmaceuticals Announces a Proof of Concept Trial of Danazol in the Treatment of Allergic Rhinitis Supports Mechanism of Action of Optina™
10. Ampio Pharmaceuticals Receives Notice of Allowance of its Two Patent Applications on the Combination of Zertane™ with Erectile Dysfunction Drugs in Canada
11. Ampio Announces Positive Results From 12-Week Open Label Extension Study of Zertane™ in Patients With Premature Ejaculation.

Post Your Comments:

(Date:5/22/2013)... 22, 2013 Upsher-Smith Laboratories, Inc. ... its global Phase III clinical trial for ... for the management of epilepsy in adults, ... is specifically engineered to provide convenient once-daily ... levels observed with currently available treatment options. ...

(Date:5/22/2013)... Life Line Screening (LLS), a leading ... creation of a unique partnership with MCM Solutions ... is a population health management organization. LLS will provide ... These important expanded services will help MCM and its ... reduces cost of care when individuals are able to ...

(Date:5/22/2013)... -- Ranbaxy Laboratories Limited (hereafter, Ranbaxy), a subsidiary ... announced on May 22 the actions that Ranbaxy ... conduct under prior management ( ... to support Ranbaxy in its efforts to address ... led to the investigations by the U.S. Department ...

Breaking Medicine Technology:Upsher-Smith Successfully Completes Phase III Study Of USL255 (Extended-Release Topiramate) For Adjunctive Treatment Of Epilepsy In Patients With Refractory Partial-Onset Seizures 2 Upsher-Smith Successfully Completes Phase III Study Of USL255 (Extended-Release Topiramate) For Adjunctive Treatment Of Epilepsy In Patients With Refractory Partial-Onset Seizures 3 Upsher-Smith Successfully Completes Phase III Study Of USL255 (Extended-Release Topiramate) For Adjunctive Treatment Of Epilepsy In Patients With Refractory Partial-Onset Seizures 4 Life Line Screening and MCM Solutions for Better Health Announce New Partnership 2

[0] Upsher-Smith Successfully Completes Phase III Study Of USL255 (Extended-Release Topiramate) For Adjunctive Treatment Of Epilepsy In Patients With Refractory Partial-Onset Seizures [0] Life Line Screening and MCM Solutions for Better Health Announce New Partnership [0] Ranbaxy Announces Improved Business Standards and Quality Assurance Initiatives

... Aethlon Medical, Inc., (OTCBB: AEMD) disclosed today that its ... following letter to shareholders. (Photo: ... Last December, I authored a shareholder letter which referenced ... for innovative new therapeutic strategies to evolve as escalating ...

... Name Medical Center (HNMC) in Teaneck, NJ, announced ... Management (PM) and revenue cycle management (RCM) software ... for distribution to hospital-affiliated physicians under the federal ... testing—including speed, functionality, and interfaces—to reach this benchmark. ...

Cached Medicine Technology:Aethlon Medical Releases Shareholder Letter 2 Aethlon Medical Releases Shareholder Letter 3 Aethlon Medical Releases Shareholder Letter 4 Aprima Earns High Marks at Holy Name Medical Center 2 Aprima Earns High Marks at Holy Name Medical Center 3

Aethlon Medical Releases Shareholder Letter Aprima Earns High Marks at Holy Name Medical Center

(Date:5/22/2013)... 22, 2013 People in the United States ... to water shortages. In much of the world, water shortages ... advocate, Sharon Kleyne. She warns against taking water for granted ... is available so easily in the United States. , Sharon ... Water radio show, heard live or by podcast on World ...

(Date:5/22/2013)... Bodybuilding.com is giving back to those who have ... be donating $1 from EVERY purchase made between 12:01am – ... grateful for the men and women who have served our ... founder of Bodybuilding.com. “It’s an honor to give back to ... USA is an amazing organization that supports our nation’s veterans ...

(Date:5/22/2013)... May 22, 2013 Twenty student-led startup ... year participating in an intensive startup accelerator designed to ... or services and create local jobs as part of ... year the Edson initiative offers approximately 20 student teams ... mentorship and training to launch their for-profit, more-than-profit or ...

(Date:5/22/2013)... Researchers in genomic health disparities from the University ... University School of Medicine have teamed up to hold ... Eliminate Health Disparities in Genomic Medicine." The theme ... nonprofits, business and government to reduce these disparities. , ... United States, individuals within underserved groups continue to be ...

(Date:5/22/2013)... report that hospitals may be reaping enormous income ... preventable bloodstream infections contracted in their intensive care ... online in the American Journal of Medical ... patient who develops an avoidable central line-associated bloodstream ... care for than a similar infection-free patient. Moreover, ...

[0] Water Advocate Sharon Kleyne Announces Water Conservation Appreciation [0] In the Spirit of Memorial Day, Bodybuilding.com is Donating a Portion of Their Sales to Hire Heroes [0] ASU Announces Edson Student Entrepreneur Initiative’s 2013-2014 Cohort [0] Why We Can't Wait: Conference to Eliminate Health Disparities in Genomic Medicine [0] Hospitals profit when patients develop bloodstream infections

... among patients on chemotherapy , , SUNDAY, June 1 (HealthDay ... side effects of treatment for head and neck cancer ... of acupuncture. , A new study found significant reductions ... after neck dissection in patients receiving acupuncture. , "Although ...

... evidence for the first time suggests that people suffering ... a progressive worsening of their nasal passage functioning, depending ... a new study published in the June 2008 edition ... study, authored by researchers in Italy, discovered that in ...

... Gemzar, everolimus almost doubled survival time with pancreatic, ... (HealthDay News) -- Patients diagnosed with pancreatic cancer ... nearly doubled their overall survival when the cancer ... shows. , Unfortunately, only about 15 percent of ...

... all subtypes of disease, researchers say , , SATURDAY, May ... trial of the biologic drug Erbitux on patients with ... by about five weeks when combined with chemotherapy. ... but the question has been by how much. , ...

... unanticipated side effects, researchers report , , SATURDAY, May 31 (HealthDay ... risk of breast cancer recurrence in premenopausal women with early ... women who took Zometa (zoledronic acid) had a 30 percent ... other benefits as well. , "We found not only an ...

... NEW YORK (May 29, 2008) -- Leading oncologists ... Center are presenting new basic and clinical research ... Oncology (ASCO) annual meeting in Chicago, May 30 ... presentations and posters to be made by NewYork-Presbyterian/Weill ...

Cached Medicine News:Health News:Acupuncture Eases Side Effects of Head, Neck Cancer Treatments 2 Health News:Acupuncture Eases Side Effects of Head, Neck Cancer Treatments 3 Health News:New Hope for Tough-to-Treat Cancers 2 Health News:New Hope for Tough-to-Treat Cancers 3 Health News:Erbitux Plus Chemo Improves Lung Cancer Outcomes 2 Health News:Bone Drug Lowers Risk of Breast Cancer Recurrence 2 Health News:NYP/Weill Cornell physician-scientists present latest cancer findings at ASCO meeting 2 Health News:NYP/Weill Cornell physician-scientists present latest cancer findings at ASCO meeting 3 Health News:NYP/Weill Cornell physician-scientists present latest cancer findings at ASCO meeting 4

Acupuncture Eases Side Effects of Head, Neck Cancer Treatments Long-term bouts with hay fever worsen ability to breathe through your nose New Hope for Tough-to-Treat Cancers Erbitux Plus Chemo Improves Lung Cancer Outcomes Bone Drug Lowers Risk of Breast Cancer Recurrence NYP/Weill Cornell physician-scientists present latest cancer findings at ASCO meeting

... evenly and safely, the Hoefer GD 2000 uses ... applied beneath the gel through a heavy aluminum ... up to 33 x 44 cm in as ... provides even heat distribution and even vacuum distribution ...

This double-up gel dryer system, 200-240 V, includes 2 Model 583 gel dryers, HydroTech™ vacuum pump, and double-up rack....

... a hot air drying device for polyacrylamide and ... cellophane support for easy viewing. The assembly table ... surface for the drying frame. The dryer holds ... 115 V, 60 Hz system includes a gel ...

The GelAir™ dryer is a component of the GelAir drying system. Supplied as a 115 V, 60 Hz gel drying oven....

Medicine Products:

GD 2000 Vacuum Gel Dryer System, 230 VAC Double-Up Gel Dryer System (220/240 V)GelAir™ Drying System (115 V, 60 Hz)GelAir™ Dryer (115 V, 60 Hz)